Temporal patterns of atrial arrhythmia recurrences in patients with implantable defibrillators: Implications for assessing antiarrhythmic therapies

被引:18
|
作者
Shehadeh, LA
Liebovitch, LS
Wood, MA
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia, Richmond, VA 23219 USA
[2] Florida Atlantic Univ, Ctr Complex Syst & Brain Sci, Ctr Mol Biol & Biotechnol, Dept Psychol, Boca Raton, FL 33431 USA
[3] Florida Atlantic Univ, Ctr Complex Syst & Brain Sci, Ctr Mol Biol & Biotechnol, Dept Biomed Sci, Boca Raton, FL 33431 USA
关键词
atrial tachycardia; atrial fibrillation; fractal; implantable cardioverter defibrillator;
D O I
10.1046/j.1540-8167.2002.00303.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The statistical measures commonly used to assess therapies for recurrent atrial arrhythmias (such as time to first recurrence) often assume a uniformly random pattern of arrhythmic events over time. However, the true temporal pattern of atrial arrhythmia recurrences is unknown. The aim of this study was to use linear and nonlinear analyses to characterize the temporal pattern of atrial arrhythmia recurrences in patients with implantable cardioverter defibrillators. Methods and Results: The time and date of atrial tachyarrhythmias recorded in 65 patients with combined atrial and ventricular defibrillators were used to construct a probability density function (PDF) and a model of a Poisson distribution of arrhythmic events for each patient. Average patient age was 66 +/- 10 years and follow-up was 7.8 +/- 4.8 months. A total of 10,759 episodes of atrial tachyarrhythmias were analyzed (range 43 to 618 episodes per patient). The PDF fit a power law distribution for all 65 patients, with an average r(2) = 0.89 +/- 0.08. The PDF distribution differed significantly from the model Poisson distribution in 47 of 65 patients (P = 0.0002). Differences from the Poisson distribution were noted for patients both taking (30/43 patients; P less than or equal to 0.015) and not taking (17/22 patients; P less than or equal to 0.017) antiarrhythmic drugs. Median time between atrial arrhythmia detections for all 65 patients was 10.8 minutes. Conclusion: In implantable cardioverter defibrillator patients, the temporal pattern of frequent recurrences of atrial tachyarrhythmias usually is characterized by a power law distribution. The unique statistical properties of this type of distribution should be considered in designing outcome measures for treatment of atrial tachyarrhythmias.
引用
收藏
页码:303 / 309
页数:7
相关论文
共 50 条
  • [1] Is there a role for antiarrhythmic drugs in patients with implantable defibrillators?
    Ho A.
    Assadi R.
    Pai S.M.
    Pai R.G.
    Current Cardiology Reports, 2006, 8 (5) : 365 - 369
  • [2] Temporal patterns of atrial fibrillation occurrences and heart failure hospitalizations in patients wearing implantable biventricular defibrillators
    Lunati, M.
    Landolina, M.
    Boriani, G.
    Santini, M.
    Botto, G. L.
    Padeletti, L.
    Pierantozzi, A.
    Gioia, M.
    Bancala, E.
    Gasparini, M.
    EUROPEAN HEART JOURNAL, 2010, 31 : 411 - 411
  • [3] Atrial Fibrillation in Patients with Implantable Defibrillators
    Sakhuja, Rahul
    Shah, Ashok J.
    Keebler, Mary
    Thakur, Ranjan K.
    CARDIOLOGY CLINICS, 2009, 27 (01) : 151 - +
  • [4] Adjuvant Antiarrhythmic Therapy in Patients with Implantable Cardioverter Defibrillators
    Bunch, T. Jared
    Anderson, Jeffrey L.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2014, 14 (02) : 89 - 100
  • [5] Adjuvant Antiarrhythmic Therapy in Patients with Implantable Cardioverter Defibrillators
    T. Jared Bunch
    Jeffrey L. Anderson
    American Journal of Cardiovascular Drugs, 2014, 14 : 89 - 100
  • [6] Role of antiarrhythmic drugs in patients with implantable cardioverter defibrillators
    Van Herendael, Hugo
    Pinter, Arnold
    Ahmad, Kamran
    Korley, Victoria
    Mangat, Iqwal
    Dorian, Paul
    EUROPACE, 2010, 12 (05): : 618 - 625
  • [7] Antiarrhythmic drugs in patients with implantable cardioverter- defibrillators
    Bollmann A.
    Husser D.
    Cannom D.S.
    American Journal of Cardiovascular Drugs, 2005, 5 (6) : 371 - 378
  • [8] INFLUENZA EPIDEMICS ARE ASSOCIATED WITH AN INCREASED RISK OF VENTRICULAR ARRHYTHMIA THERAPIES IN PATIENTS WITH IMPLANTABLE CARDIAC DEFIBRILLATORS OR CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS
    Madjid, Mohammad
    Connolly, Allison T.
    Nabutovsky, Yelena
    Safavi-Naeini, Payam
    Miller, Charles C.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1736 - 1736
  • [9] Implantable defibrillators and antiarrhythmic drugs in patients at risk for lethal arrhythmias
    Zivin, A
    Bardy, GH
    AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (9A): : 63R - 68R
  • [10] Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies
    Purerfellner, H
    Gillis, AM
    Holbrook, R
    Hettrick, DA
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2004, 27 (07): : 983 - 992